INSIGHT. Today’s cancer screening programmes largely focus on detecting one type of cancer at a time, such as breast, cervical or colorectal cancer. For many other types of cancer, established population-based screening programmes are not available, limiting opportunities to systematically detect the disease before symptoms appear. Multi-Cancer Early Detection (MCED)
PRESS RELEASE. Sciety welcomes Thomas Eldered as Senior Advisor. Thomas has over 35 years of experience in the pharmaceutical industry and is co-founder of Recipharm and founder of the investment firm Flerie. His background as an entrepreneur, business leader and investor brings valuable perspectives on investments and building successful companies
PRESS RELEASE. Sciety’s Board of Directors has appointed Anna Sundin as the company’s new CEO. She succeeds one of Sciety’s founders, Andreas Lindblom, who will continue in an operational role as Managing Partner. Anna Sundin has 25 years of experience in the financial sector and joins Sciety from BearingPoint, where
Sciety is a long-term capital partner in healthcare, focused on the Nordic region. We work with selected growth companies and lead capital-raising processes from analysis and positioning to investor dialogue and execution. Through our network of family offices, investment companies, venture capital firms and private investors, we connect companies with
Sciety is a long-term capital partner in healthcare, focused on the Nordic region. We work with selected growth companies and lead capital-raising processes from analysis and positioning to investor dialogue and execution. Through our network of family offices, investment companies, venture capital firms and private investors, we connect companies with
Sciety is a capital partner specialising in life science and healthcare, offering services in capital raising and related areas. Sciety may currently have, may previously have had or may in the future be engaged by companies mentioned in our communications or operating in the sectors described, and may hold ownership interests in such companies. Sciety receives remuneration for its services, including commissions in connection to capital raises. Our communication is intended for informational purposes only and does not constitute personal investment advice. We do not guarantee the accuracy, completeness or timeliness of the information provided. Investment decisions should not be based solely on this communication.
